+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Small Molecule Drug"

Gastrointestinal Stromal Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

Gastrointestinal Stromal Tumors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 85 Pages
  • Global
From
Recurrent Or Metastatic Head And Neck Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Recurrent Or Metastatic Head And Neck Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Urothelial Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Urothelial Carcinoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 170 Pages
  • Global
From
Mesothelioma - Pipeline Insight, 2025 - Product Thumbnail Image

Mesothelioma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Metastatic Urothelial Carcinoma- Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Urothelial Carcinoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 150 Pages
  • Global
From
Proto Oncogene Protein C-akt Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Proto Oncogene Protein C-akt Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
BET Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

BET Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
TIL Therapy - Pipeline Insight, 2025 - Product Thumbnail Image

TIL Therapy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Advanced Merkel Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Merkel Cell Carcinoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Squamous Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Squamous Cell Carcinoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 240 Pages
  • Global
From
Janus Kinase (JAK) Inhibitors- Pipeline Insight, 2025 - Product Thumbnail Image

Janus Kinase (JAK) Inhibitors- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 150 Pages
  • Global
From
Sensorineural Hearing Loss (SHL) - Pipeline Insight, 2025 - Product Thumbnail Image

Sensorineural Hearing Loss (SHL) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Metastatic Hepatocellular Carcinoma- Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Hepatocellular Carcinoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Synovial Sarcoma - Pipeline Insight, 2025 - Product Thumbnail Image

Synovial Sarcoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
PI3K Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

PI3K Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 150 Pages
  • Global
From
Anti-CD20 Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD20 Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
DNA Topoisomerase I Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

DNA Topoisomerase I Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Peritoneal Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Peritoneal Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
TCR Therapy- Pipeline Insight, 2025 - Product Thumbnail Image

TCR Therapy- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 280 Pages
  • Global
From
Loading Indicator

The Small Molecule Drug market is a segment of the Pharmaceuticals industry that focuses on the development and production of drugs composed of small molecules. These drugs are typically used to treat a wide range of diseases, including cancer, diabetes, and cardiovascular diseases. Small molecule drugs are typically taken orally, and are designed to target specific areas of the body. The Small Molecule Drug market is highly competitive, with many companies vying for market share. Companies in the market include Pfizer, Merck, Novartis, GlaxoSmithKline, AstraZeneca, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of small molecule drugs, as well as the marketing and distribution of these drugs. Show Less Read more